[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Pet Drug Market Research Report 2023

December 2023 | 87 pages | ID: G70A61392FDAEN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, we study the Veterinary Products for Pet mainly medicines

According to QYResearch’s new survey, global Pet Drug market is projected to reach US$ 20540 million in 2029, increasing from US$ 12930 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pet Drug market research.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 458%.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pet Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
  • Zoetis
  • Boehringer Ingelheim
  • Merck Animal Health
  • Elanco Animal Health
  • Virbac
  • Dechra Veterinary Products
  • Ceva
  • Vetoquinol
  • Meiji
  • Ouro Fino Saude
  • Parnell
Segment by Type
  • Antiparasitic Drugs
  • Antibacterial
  • Other
Segment by Application
  • Dogs
  • Cats
  • Other
By Region
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
The Pet Drug report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Pet Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Antiparasitic Drugs
  1.2.3 Antibacterial
  1.2.4 Other
1.3 Market by Application
  1.3.1 Global Pet Drug Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Dogs
  1.3.3 Cats
  1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Pet Drug Market Perspective (2018-2029)
2.2 Pet Drug Growth Trends by Region
  2.2.1 Global Pet Drug Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Pet Drug Historic Market Size by Region (2018-2023)
  2.2.3 Pet Drug Forecasted Market Size by Region (2024-2029)
2.3 Pet Drug Market Dynamics
  2.3.1 Pet Drug Industry Trends
  2.3.2 Pet Drug Market Drivers
  2.3.3 Pet Drug Market Challenges
  2.3.4 Pet Drug Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pet Drug Players by Revenue
  3.1.1 Global Top Pet Drug Players by Revenue (2018-2023)
  3.1.2 Global Pet Drug Revenue Market Share by Players (2018-2023)
3.2 Global Pet Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Drug Revenue
3.4 Global Pet Drug Market Concentration Ratio
  3.4.1 Global Pet Drug Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Pet Drug Revenue in 2022
3.5 Pet Drug Key Players Head office and Area Served
3.6 Key Players Pet Drug Product Solution and Service
3.7 Date of Enter into Pet Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 PET DRUG BREAKDOWN DATA BY TYPE

4.1 Global Pet Drug Historic Market Size by Type (2018-2023)
4.2 Global Pet Drug Forecasted Market Size by Type (2024-2029)

5 PET DRUG BREAKDOWN DATA BY APPLICATION

5.1 Global Pet Drug Historic Market Size by Application (2018-2023)
5.2 Global Pet Drug Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Pet Drug Market Size (2018-2029)
6.2 North America Pet Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pet Drug Market Size by Country (2018-2023)
6.4 North America Pet Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Pet Drug Market Size (2018-2029)
7.2 Europe Pet Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pet Drug Market Size by Country (2018-2023)
7.4 Europe Pet Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Pet Drug Market Size (2018-2029)
8.2 Asia-Pacific Pet Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pet Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Pet Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Pet Drug Market Size (2018-2029)
9.2 Latin America Pet Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pet Drug Market Size by Country (2018-2023)
9.4 Latin America Pet Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Pet Drug Market Size (2018-2029)
10.2 Middle East & Africa Pet Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pet Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Pet Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Zoetis
  11.1.1 Zoetis Company Detail
  11.1.2 Zoetis Business Overview
  11.1.3 Zoetis Pet Drug Introduction
  11.1.4 Zoetis Revenue in Pet Drug Business (2018-2023)
  11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
  11.2.1 Boehringer Ingelheim Company Detail
  11.2.2 Boehringer Ingelheim Business Overview
  11.2.3 Boehringer Ingelheim Pet Drug Introduction
  11.2.4 Boehringer Ingelheim Revenue in Pet Drug Business (2018-2023)
  11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
  11.3.1 Merck Animal Health Company Detail
  11.3.2 Merck Animal Health Business Overview
  11.3.3 Merck Animal Health Pet Drug Introduction
  11.3.4 Merck Animal Health Revenue in Pet Drug Business (2018-2023)
  11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
  11.4.1 Elanco Animal Health Company Detail
  11.4.2 Elanco Animal Health Business Overview
  11.4.3 Elanco Animal Health Pet Drug Introduction
  11.4.4 Elanco Animal Health Revenue in Pet Drug Business (2018-2023)
  11.4.5 Elanco Animal Health Recent Development
11.5 Virbac
  11.5.1 Virbac Company Detail
  11.5.2 Virbac Business Overview
  11.5.3 Virbac Pet Drug Introduction
  11.5.4 Virbac Revenue in Pet Drug Business (2018-2023)
  11.5.5 Virbac Recent Development
11.6 Dechra Veterinary Products
  11.6.1 Dechra Veterinary Products Company Detail
  11.6.2 Dechra Veterinary Products Business Overview
  11.6.3 Dechra Veterinary Products Pet Drug Introduction
  11.6.4 Dechra Veterinary Products Revenue in Pet Drug Business (2018-2023)
  11.6.5 Dechra Veterinary Products Recent Development
11.7 Ceva
  11.7.1 Ceva Company Detail
  11.7.2 Ceva Business Overview
  11.7.3 Ceva Pet Drug Introduction
  11.7.4 Ceva Revenue in Pet Drug Business (2018-2023)
  11.7.5 Ceva Recent Development
11.8 Vetoquinol
  11.8.1 Vetoquinol Company Detail
  11.8.2 Vetoquinol Business Overview
  11.8.3 Vetoquinol Pet Drug Introduction
  11.8.4 Vetoquinol Revenue in Pet Drug Business (2018-2023)
  11.8.5 Vetoquinol Recent Development
11.9 Meiji
  11.9.1 Meiji Company Detail
  11.9.2 Meiji Business Overview
  11.9.3 Meiji Pet Drug Introduction
  11.9.4 Meiji Revenue in Pet Drug Business (2018-2023)
  11.9.5 Meiji Recent Development
11.10 Ouro Fino Saude
  11.10.1 Ouro Fino Saude Company Detail
  11.10.2 Ouro Fino Saude Business Overview
  11.10.3 Ouro Fino Saude Pet Drug Introduction
  11.10.4 Ouro Fino Saude Revenue in Pet Drug Business (2018-2023)
  11.10.5 Ouro Fino Saude Recent Development
11.11 Parnell
  11.11.1 Parnell Company Detail
  11.11.2 Parnell Business Overview
  11.11.3 Parnell Pet Drug Introduction
  11.11.4 Parnell Revenue in Pet Drug Business (2018-2023)
  11.11.5 Parnell Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES

Table 1. Global Pet Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antiparasitic Drugs
Table 3. Key Players of Antibacterial
Table 4. Key Players of Other
Table 5. Global Pet Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Pet Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Pet Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Pet Drug Market Share by Region (2018-2023)
Table 9. Global Pet Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Pet Drug Market Share by Region (2024-2029)
Table 11. Pet Drug Market Trends
Table 12. Pet Drug Market Drivers
Table 13. Pet Drug Market Challenges
Table 14. Pet Drug Market Restraints
Table 15. Global Pet Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Pet Drug Market Share by Players (2018-2023)
Table 17. Global Top Pet Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug as of 2022)
Table 18. Ranking of Global Top Pet Drug Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Pet Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pet Drug Product Solution and Service
Table 22. Date of Enter into Pet Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pet Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Pet Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Pet Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Pet Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Pet Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Pet Drug Revenue Market Share by Application (2018-2023)
Table 30. Global Pet Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Pet Drug Revenue Market Share by Application (2024-2029)
Table 32. North America Pet Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Pet Drug Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Pet Drug Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Pet Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Pet Drug Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Pet Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Pet Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Pet Drug Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Pet Drug Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Pet Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Pet Drug Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Pet Drug Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Pet Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Pet Drug Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Pet Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. Zoetis Company Detail
Table 48. Zoetis Business Overview
Table 49. Zoetis Pet Drug Product
Table 50. Zoetis Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 51. Zoetis Recent Development
Table 52. Boehringer Ingelheim Company Detail
Table 53. Boehringer Ingelheim Business Overview
Table 54. Boehringer Ingelheim Pet Drug Product
Table 55. Boehringer Ingelheim Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 56. Boehringer Ingelheim Recent Development
Table 57. Merck Animal Health Company Detail
Table 58. Merck Animal Health Business Overview
Table 59. Merck Animal Health Pet Drug Product
Table 60. Merck Animal Health Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 61. Merck Animal Health Recent Development
Table 62. Elanco Animal Health Company Detail
Table 63. Elanco Animal Health Business Overview
Table 64. Elanco Animal Health Pet Drug Product
Table 65. Elanco Animal Health Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 66. Elanco Animal Health Recent Development
Table 67. Virbac Company Detail
Table 68. Virbac Business Overview
Table 69. Virbac Pet Drug Product
Table 70. Virbac Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 71. Virbac Recent Development
Table 72. Dechra Veterinary Products Company Detail
Table 73. Dechra Veterinary Products Business Overview
Table 74. Dechra Veterinary Products Pet Drug Product
Table 75. Dechra Veterinary Products Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 76. Dechra Veterinary Products Recent Development
Table 77. Ceva Company Detail
Table 78. Ceva Business Overview
Table 79. Ceva Pet Drug Product
Table 80. Ceva Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 81. Ceva Recent Development
Table 82. Vetoquinol Company Detail
Table 83. Vetoquinol Business Overview
Table 84. Vetoquinol Pet Drug Product
Table 85. Vetoquinol Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 86. Vetoquinol Recent Development
Table 87. Meiji Company Detail
Table 88. Meiji Business Overview
Table 89. Meiji Pet Drug Product
Table 90. Meiji Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 91. Meiji Recent Development
Table 92. Ouro Fino Saude Company Detail
Table 93. Ouro Fino Saude Business Overview
Table 94. Ouro Fino Saude Pet Drug Product
Table 95. Ouro Fino Saude Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 96. Ouro Fino Saude Recent Development
Table 97. Parnell Company Detail
Table 98. Parnell Business Overview
Table 99. Parnell Pet Drug Product
Table 100. Parnell Revenue in Pet Drug Business (2018-2023) & (US$ Million)
Table 101. Parnell Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Pet Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pet Drug Market Share by Type: 2022 VS 2029
Figure 3. Antiparasitic Drugs Features
Figure 4. Antibacterial Features
Figure 5. Other Features
Figure 6. Global Pet Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Pet Drug Market Share by Application: 2022 VS 2029
Figure 8. Dogs Case Studies
Figure 9. Cats Case Studies
Figure 10. Other Case Studies
Figure 11. Pet Drug Report Years Considered
Figure 12. Global Pet Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Pet Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pet Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Pet Drug Market Share by Players in 2022
Figure 16. Global Top Pet Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pet Drug Revenue in 2022
Figure 18. North America Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Pet Drug Market Share by Country (2018-2029)
Figure 20. United States Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pet Drug Market Share by Country (2018-2029)
Figure 24. Germany Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pet Drug Market Share by Region (2018-2029)
Figure 32. China Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pet Drug Market Share by Country (2018-2029)
Figure 40. Mexico Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pet Drug Market Share by Country (2018-2029)
Figure 44. Turkey Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Pet Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Zoetis Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 48. Merck Animal Health Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 49. Elanco Animal Health Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 50. Virbac Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 51. Dechra Veterinary Products Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 52. Ceva Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 53. Vetoquinol Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 54. Meiji Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 55. Ouro Fino Saude Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 56. Parnell Revenue Growth Rate in Pet Drug Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed


More Publications